Company Filing History:
Years Active: 2011
Title: Wilfried Renner: Innovator in Cardiovascular Disease Diagnosis and Treatment
Introduction
Wilfried Renner is a notable inventor based in Graz, Austria. He has made significant contributions to the field of medical technology, particularly in the diagnosis and treatment of cardiovascular diseases. His innovative approach has the potential to improve patient outcomes and advance medical practices.
Latest Patents
Renner holds a patent for a method for the diagnosis and treatment of cardiovascular diseases. This invention focuses on the in vitro or in vivo diagnosis of conditions such as high blood pressure, stenosis, vessel occlusion, and other thrombotic events. The method involves determining the nucleotide at position 950 of a nucleic acid coding for the human ARK2 protein or the amino acid at position 298 of the human ARK2 protein from a sample of a person. Additionally, the invention highlights the use of ARK2 for the development and production of a medicament aimed at treating cardiovascular diseases. He has 1 patent to his name.
Career Highlights
Wilfried Renner is associated with Sanofi-Aventis, a global healthcare leader. His work at the company has allowed him to focus on innovative solutions in the medical field. Renner's dedication to research and development has positioned him as a key player in advancing cardiovascular health.
Collaborations
Throughout his career, Renner has collaborated with esteemed colleagues such as Detlef Kozian and Matthias Herrmann. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Wilfried Renner's contributions to the diagnosis and treatment of cardiovascular diseases exemplify the impact of innovation in healthcare. His work not only enhances medical understanding but also paves the way for future advancements in the field.